Table 2.
Example topics in papers discussing mental illness epidemiology, treatment and outcome
| Disorder (% of papers) | Descriptive epidemiology and service use | Risk factors, comorbidities and genetics | Treatment and prognosis | Physical health, pregnancy, mortality | 
|---|---|---|---|---|
| All disorders (10 %) | Manson [148] Heggestadet al. [149]  | 
Roque et al. [150] Cross-Disorder Group of the Psychiatric Genomics [59]  | 
Donisi et al. [89] | Perini et al. [151] Lawrence et al. [82]  | 
| Severe mental illness (5 %) | Lyalina et al. [152] | Kyaga et al. [153] Steinberg et al. [154]  | 
Perlman et al. [112] | Matheson et al. [155] Wangel et al. [156]  | 
| Dementia (9 %) | Knopman et al. [24] Kosteniuk et al. [157]  | 
Exalto et al. [158] Lambert et al. [145]  | 
van den Bussche et al. [159] | Rait et al. [160] | 
| Substance use disorder (2 %) | Bonn-Miller et al. [161] | Nesvåg [162] | Mark et al. [163] | |
| Schizophrenia (6 %) | Okkels et al. [164] Evensen et al. [102]  | 
Harper et al. [165] | Stroup et al. [166] | Gal et al. [167] Vigod et al. [168]  | 
| Bipolar disorder (2 %) | Castro et al. [169] | Schaefer et al. [170] | Hayes et al. [171] | Lee and Lin [172] | 
| Depressive disorders (11 %) | Hoffmann et al. [173] Wong et al. [35]  | 
Hanauer et al. [137] Ul-Haq et al. [174]  | 
Morkem et al. [34] Musliner et al. [175]  | 
Lin et al. [119] | 
| Anxiety and somatoform disorders (2 %) | Walters et al. [75] | Lacourt et al. [176] | Sandelin et al. [177] | Frayne et al. [178] | 
| Eating disorders (1 %) | Micali et al. [179] | Reichborn-Kjennerudet al. [142] | ||
| Post-partum mental disorders (2 %) | Polachek et al. [180] | Goyal et al. [130] | ||
| Intellectual disabilities (1 %) | Sprung et al. [181] | Alexander et al. [182] | ||
| Autism/Autism Spectrum Disorder (ASD) (6 %) | Kohane [134] | Hsu et al. [183] Clarke et al. [184]  | 
Wong et al. [144] Murphy and Spooren [107]  | 
|
| Other neuro-developmental disorders (4 %) | Surén et al. [185] | Leivonen et al. [186] | Hoffmannet al. [187] |